MediPharm Labs Management
Management criteria checks 3/4
MediPharm Labs' CEO is David Pidduck, appointed in Apr 2022, has a tenure of 2.58 years. total yearly compensation is CA$1.31M, comprised of 36% salary and 64% bonuses, including company stock and options. directly owns 4.08% of the company’s shares, worth CA$1.09M. The average tenure of the management team and the board of directors is 5.1 years and 5.4 years respectively.
Key information
David Pidduck
Chief executive officer
CA$1.3m
Total compensation
| CEO salary percentage | 36.0% |
| CEO tenure | 2.6yrs |
| CEO ownership | 4.1% |
| Management average tenure | 5.1yrs |
| Board average tenure | 5.4yrs |
Recent management updates
Recent updates
MediPharm Labs Corp. (TSE:LABS) Doing What It Can To Lift Shares
Oct 11
MediPharm Labs (TSE:LABS) Is Using Debt Safely
May 29Market Might Still Lack Some Conviction On MediPharm Labs Corp. (TSE:LABS) Even After 31% Share Price Boost
Mar 23Does MediPharm Labs (TSE:LABS) Have A Healthy Balance Sheet?
Jan 10MediPharm Labs (TSE:LABS) Has Debt But No Earnings; Should You Worry?
Sep 06MediPharm Labs Corp. (TSE:LABS) Stocks Shoot Up 27% But Its P/S Still Looks Reasonable
Apr 17Time To Worry? Analysts Just Downgraded Their MediPharm Labs Corp. (TSE:LABS) Outlook
Aug 20Some Analysts Just Cut Their MediPharm Labs Corp. (TSE:LABS) Estimates
May 21Things Look Grim For MediPharm Labs Corp. (TSE:LABS) After Today's Downgrade
Apr 06Is MediPharm Labs (TSE:LABS) Using Too Much Debt?
Mar 07Does MediPharm Labs (TSE:LABS) Have A Healthy Balance Sheet?
Aug 18Some MediPharm Labs Corp. (TSE:LABS) Analysts Just Made A Major Cut To Next Year's Estimates
May 23CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -CA$12m |
| Jun 30 2024 | n/a | n/a | -CA$13m |
| Mar 31 2024 | n/a | n/a | -CA$14m |
| Dec 31 2023 | CA$1m | CA$470k | -CA$13m |
| Sep 30 2023 | n/a | n/a | -CA$16m |
| Jun 30 2023 | n/a | n/a | -CA$20m |
| Mar 31 2023 | n/a | n/a | -CA$26m |
| Dec 31 2022 | CA$3m | CA$315k | -CA$30m |
Compensation vs Market: David's total compensation ($USD933.68K) is above average for companies of similar size in the Canadian market ($USD169.13K).
Compensation vs Earnings: David's compensation has been consistent with company performance over the past year.
CEO
David Pidduck
2.6yrs
Tenure
CA$1,305,051
Compensation
Mr. David A. Pidduck is Chief Executive Officer and Director at MediPharm Labs Corp. since April 20, 2022. Mr. Pidduck has been the Chief Executive Officer and President of Purdue Pharma Inc. since Septemb...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 2.6yrs | CA$1.31m | 4.08% CA$ 1.1m | |
| Co-Founder & President | 5.8yrs | CA$819.48k | 2.17% CA$ 579.6k | |
| Chief Financial Officer | 3.8yrs | CA$957.75k | 0.31% CA$ 84.0k | |
| Founder | 9.8yrs | CA$858.16k | no data | |
| Vice President of Sales | 4.5yrs | no data | no data | |
| Executive Vice President of Global Accounts | 5.8yrs | no data | no data |
5.1yrs
Average Tenure
Experienced Management: LABS's management team is seasoned and experienced (5.1 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 2.6yrs | CA$1.31m | 4.08% CA$ 1.1m | |
| Independent Director | 4.4yrs | CA$64.49k | 0.020% CA$ 5.2k | |
| Independent Director | 1.6yrs | CA$34.45k | 0.050% CA$ 13.4k | |
| Independent Chairman of the Board | 4.3yrs | CA$87.14k | 0.35% CA$ 92.5k | |
| Member of the Science Advisory Board | 5.6yrs | CA$32.40k | no data | |
| Member of the Science Advisory Board | 5.6yrs | no data | no data | |
| Member of the Science Advisory Board | 5.6yrs | no data | no data | |
| Member of the Science Advisory Board | 5.6yrs | no data | no data | |
| Member of the Science Advisory Board | 5.6yrs | no data | no data | |
| Member of the Science Advisory Board | 5.6yrs | no data | no data | |
| Member of the Science Advisory Board | 5.3yrs | no data | no data | |
| Independent Director | 4.3yrs | CA$56.05k | 0.043% CA$ 11.4k |
5.4yrs
Average Tenure
Experienced Board: LABS's board of directors are considered experienced (5.4 years average tenure).